{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:04:52Z","timestamp":1766073892241,"version":"3.48.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Uveitic macular edema (UME) is a leading cause of vision loss in uveitis. Although anti-inflammatory and immunosuppressive agents remain the mainstay of UME treatment, their use is often limited by corticosteroid-related side effects and the high cost of immunosuppressive therapies. This review aims to summarize the current evidence on carbonic anhydrase inhibitors as a potential treatment option for UME.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Electronic searches were conducted in PubMed\/MEDLINE, Scopus, Google Scholar, Sage Journals, EBSCOhost, and the Cochrane Library for interventional and observational studies evaluating carbonic anhydrase inhibitors in UME. Eligible studies reported outcomes including UME resolution, recurrence, central macular thickness change, visual acuity improvement, and adverse effects. Two reviewers independently screened and extracted data, and assessed study quality and risk of bias. Meta-analysis of proportions was performed using a random-effects model. This study was registered in PROSPERO (CRD42024528004).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Seven studies with a total of 187 participants (236 eyes) were included. All investigated oral acetazolamide. The pooled proportion of visual acuity improvement was 53% (95% CI: 45%\u201360%), and anatomical improvement was 55% (95% CI: 32%\u201379%). Acetazolamide showed a 14% higher likelihood of improving visual acuity compared with placebo, although not statistically significant (risk difference: 0.14; 95% CI: \u22120.04 to 0.31;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.12).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Carbonic anhydrase inhibitors, particularly oral acetazolamide, offer a potential alternative for managing UME, especially for patients who are refractory to steroids or are steroid-responders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004646","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T21:00:08Z","timestamp":1756328408000},"page":"4-14","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CARBONIC ANHYDRASE INHIBITORS FOR MANAGING UVEITIC MACULAR EDEMA"],"prefix":"10.1097","volume":"46","author":[{"given":"Tifanni","family":"Excelinda","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Universitas Indonesia\u2014Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikhwanuliman","family":"Putera","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Universitas Indonesia\u2014Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia;"},{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands; and"},{"name":"Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands."},{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Internal Medicine Section Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asri Salima","family":"Ridwan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Universitas Indonesia\u2014Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"La Distia Nora","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Universitas Indonesia\u2014Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia;"},{"name":"Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"695904","DOI":"10.3389\/fmed.2021.695904","article-title":"Epidemiology and risk factors in non-infectious uveitis: a systematic review","volume":"8","author":"Joltikov","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/OPTH.S180580","article-title":"Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges","volume":"13","author":"Massa","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/eye.2016.115","article-title":"Uveitic macular edema","volume":"30","author":"Fardeau","year":"2016","journal-title":"Eye (Lond)"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"R5-20251218","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajo.2008.09.014","article-title":"Incidence and prevalence of uveitis in veterans affairs medical centers of the Pacific northwest","volume":"146","author":"Suhler","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/OPTH.S500339","article-title":"Prevalence and risk factors for ocular complications in new-onset uveitis: a study from a tertiary referral center in Northern Thailand","volume":"19","author":"Apivatthakakul","year":"2025","journal-title":"Clin Ophthalmol"},{"key":"R9-20251218","first-page":"759","article-title":"Clinical characteristics of intermediate uveitis in adult Turkish patients","volume":"8","author":"Kardes","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","article-title":"Impact of macular edema on visual acuity in uveitis","volume":"113","author":"Lardenoye","year":"2006","journal-title":"Ophthalmology"},{"key":"R11-20251218","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/09273948.2018.1529466","article-title":"Uveitic macular edema","volume":"26","author":"Cunningham","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R13-20251218","doi-asserted-by":"crossref","first-page":"807319","DOI":"10.3389\/fmed.2022.807319","article-title":"The trend of drug therapy on uveitic macular edema: a bibliometric analysis of the 100 Most cited articles","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.02.017","article-title":"Association of disorganization of retinal inner layers with visual acuity in eyes with uveitic cystoid macular edema","volume":"177","author":"Grewal","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00417-009-1149-8","article-title":"Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema","volume":"247","author":"Roesel","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-20251218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.sjopt.2014.02.008","article-title":"Retinal imaging in uveitis","volume":"28","author":"Gupta","year":"2014","journal-title":"Saudi J Ophthalmol"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/09273948.2017.1367406","article-title":"The impact and implication of peripheral vascular leakage on ultra-widefield fluorescein angiography in uveitis","volume":"27","author":"Thomas","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R18-20251218","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s40135-016-0090-3","article-title":"Uveitic macular edema: treatment update","volume":"4","author":"Goldhardt","year":"2016","journal-title":"Curr Ophthalmol Rep"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17469899.2019.1644168","article-title":"Recent progress in the treatment of uveitic macular edema","volume":"14","author":"Ad\u00e1n","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.3390\/jcm10184133","article-title":"Update on the management of uveitic macular edema","volume":"10","author":"Teper","year":"2021","journal-title":"J Clin Med"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2015.07.036","article-title":"Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results","volume":"122","author":"Tomkins-Netzer","year":"2015","journal-title":"Ophthalmology"},{"key":"R22-20251218","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12348-019-0168-9","article-title":"Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema","volume":"9","author":"Weber","year":"2019","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R23-20251218","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"key":"R24-20251218","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09273948.2015.1099680","article-title":"Tocilizumab in uveitic macular edema refractory to previous immunomodulatory treatment","volume":"25","author":"Deuter","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"R25-20251218","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10067-019-04763-3","article-title":"Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-\u03b1 inhibition: a narrative review","volume":"39","author":"Gaggiano","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R26-20251218","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00417-013-2552-8","article-title":"Anti-TNF-\u03b1 agents for refractory cystoid macular edema associated with noninfectious uveitis","volume":"252","author":"Schaap-Fogler","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R27-20251218","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/09273948.2011.645989","article-title":"Interferon alpha 2b in the treatment of uveitic cystoid macular edema","volume":"20","author":"Butler","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"R28-20251218","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/IAE.0000000000002044","article-title":"Response of inflammatory cystoid macular edema to treatment using oral acetazolamide","volume":"39","author":"Pepple","year":"2019","journal-title":"Retina"},{"key":"R29-20251218","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms24054676","article-title":"Interleukin-6 and macular edema: a review of outcomes with inhibition","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R30-20251218","doi-asserted-by":"crossref","first-page":"e0186180","DOI":"10.1371\/journal.pone.0186180","article-title":"Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: a meta-analysis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"R31-20251218","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bjo.78.1.4","article-title":"Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study","volume":"78","author":"Farber","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"R32-20251218","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R33-20251218","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006982-200502000-00011","article-title":"Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation","volume":"25","author":"Schilling","year":"2005","journal-title":"Retina"},{"key":"R35-20251218","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0161-6420(96)30567-8","article-title":"A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis","volume":"103","author":"Whitcup","year":"1996","journal-title":"Ophthalmology"},{"key":"R37-20251218","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R38-20251218","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R39-20251218","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"R49-20251218","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.eye.6700464","article-title":"Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet\u2019s disease","volume":"17","author":"Lashay","year":"2003","journal-title":"Eye (Lond)"},{"key":"R42-20251218","doi-asserted-by":"crossref","first-page":"e0234690","DOI":"10.1371\/journal.pone.0234690","article-title":"Intraocular and intracranial pressure in glaucoma patients taking acetazolamide","volume":"15","author":"Loiselle","year":"2020","journal-title":"PLoS One"},{"key":"R43-20251218","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms20153841","article-title":"Role of carbonic anhydrases and inhibitors in acid-base physiology: insights from mathematical modeling","volume":"20","author":"Occhipinti","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R44-20251218","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2005.01.003","article-title":"Ocular inflammation alters swelling and membrane characteristics of rat m\u00fcller glial cells","volume":"161","author":"Pannicke","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R46-20251218","doi-asserted-by":"crossref","first-page":"34","DOI":"10.51329\/mehdiophthal1443","article-title":"Carbonic anhydrase inhibitors in the management of macular edema: a review of the literature","volume":"11","author":"Shahsuvaryan","year":"2022","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R47-20251218","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/DDDT.S166092","article-title":"Update in treatment of uveitic macular edema","volume":"13","author":"Koronis","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R48-20251218","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2147\/OPTH.S40268","article-title":"Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis","volume":"7","author":"Karim","year":"2013","journal-title":"Clin Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:00:31Z","timestamp":1766073631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004646"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004646","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}